Researchers at Imperial College London are planning to deliberately infect healthy volunteers with the coronavirus early next year as part of the world’s first effort to study how people immunis...

India’s department of biotechnology has selected 10 cities where several thousand healthy volunteers could join the anticipated large-scale clinical trials to assess the efficacy of candidate va...

We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...

The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS in New Delhi on Friday with the first dose of the injection ...

The candidate vaccine against the new coronavirus disease developed by Oxford researchers and shown as safe and able to induce promising immune responses will be tested in India, among other countries...

Dozens of clinical trials registered on an American database and listing India among their sites for enrolment of patients are missing from India’s own database of trials, a study has revealed, ...

Through draws of lots, doctors will this week start offering patients with the new coronavirus disease at the Lady Hardinge Medical College, New Delhi, a choice of three medications — a deworming dr...

Arun Ghosh is the Ian P. Rothwell Distinguished Professor for organic and medicinal chemistry at Purdue University, US, and specialises in drug design. He discovered the drug darunavir, the frontline ...